Antifungal topical therapy in oral chronic candidosis. A comparative study;Tratamiento antifúngico tópico en pacientes con candidosis crónica bucal. Estudio comparativo

Medicina Oral

Volumn 7, Issue 4, 2002, Pages 260-270

  López de Blanc, Silvia Adriana ^a   Salati de Mugnolo, Nelly ^a   Libero Femopase, Fabián ^a   Benítez, Mónica Beatriz ^a   Morelatto, Rosana Andrea ^a   Astrada de Verde, Lucía ^a   Masih, Diana ^a  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

Author keywords

Antifungal effect; Fenticonazole; Ketoconazole; Nystatin; Oral candidosis; Topical treatment

Indexed keywords

ANTIFUNGAL AGENT; FENTICONAZOLE; KETOCONAZOLE; NYSTATIN; IMIDAZOLE DERIVATIVE;

ANTIFUNGAL ACTIVITY; ARTICLE; CHEEK MUCOSA; CHRONIC DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PALATE; RANDOMIZED CONTROLLED TRIAL; REMISSION; STATISTICAL ANALYSIS; THRUSH; TONGUE; TREATMENT OUTCOME; ANALYSIS OF VARIANCE; COMPARATIVE STUDY; DOUBLE BLIND PROCEDURE; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ANALYSIS OF VARIANCE; ANTIFUNGAL AGENTS; CANDIDIASIS, ORAL; CHRONIC DISEASE; COMPARATIVE STUDY; DOUBLE-BLIND METHOD; FEMALE; HUMAN; IMIDAZOLES; KETOCONAZOLE; MALE; NYSTATIN; HUMANS;

EID: 0036328705     PISSN: 11372834     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. The prevalence in intra-oral distribution of Candida albicans in man
2. A comparison of intraoral Candida carriage in Sjögren's syndrome patients with healthy xerostomic controls
3. Ecology of Candida and epidemiology of candidosis
4. Identification of Candida albicans types related to healthy and pathological oral mucosa
5. Prevalence of Candida species in AIDS patients and HIV-free subjects in Thailand
6. Classification and diagnostic criteria for oral lesions in HIV infection
7. Oral manifestations of HIV infection: Definitions, diagnostic criteria and principles of therapy
8. Replication of Epstein-Barr virus within the epithelial cells of "hairy" leukoplakia, an AIDS-associated lesion
9. Oral candidiasis: Etiology, pathogenesis and laboratory diagnosis
10. Biotypes of oral Candida albicans isolated from AIDS patients and HIV-free subjects in Thailand
11. Oropharyngeal and esophageal candidiasis in immunocompromised patients: Treatment issues
12. Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients
13. Oropharyngeal candidiasis in patients with AIDS: Randomized comparison of fluconazole versus nystatin oral suspensions
14. Antifungal drugs in the management of mycosis
15. Antifungal therapy in oropharyngeal mycotic infections
16. Treatment of oral candidiasis in HIV infection
17. Treatment of thrush with itraconazole solution: Evidence for topical effect
18. A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS
19. Weekly fluconazole for the prevention of mucosal candidiasis in women with HIV infection. A randomized, double-blind, placebo-controlled trial
20. Clinical evaluation of fenticonazole cream in cutaneous fungal infections: A comparison with myconazole cream
21. Efficacy and tolerance of fenticonazole versus myconazole cream
22. In vitro antimycotic activity of fenticonazole
23. A double-blind evaluation of fenticonazole cream 2% and clotrimazole cream 1% in dermatomycoses
24. Treatment of dermatomycoses with topical fenticonazole and econazole
25. Ruolo della malassezia furfur nella dermatite seborroica nell' adulto ed efficacia terapeutica del fenticonazolo
26. Fenticonazole: A new antifungal imidazole derivative. In vitro and in vivo antimycotic activity
27. Clinical characteristics and management responses in 85 HIV-infected patients with oral candidiasis
28. Photosensitivity induced by oral itraconazole
29. Reduction in oropharyngeal candidiasis following introduction of protease inhibitors
30. Fluconazole-resistant Candida species in the oral flora of fluconazole-exposed HIV-positive patients
31. Detection of Candida dubliniensis in oropharyngeal samples from Human Immunodeficiency Virus infected patients in North America by primary CHROMagar Candida Screening and susceptibility testing of isolates
32. Patterns of fluconazole susceptibility in isolates from Human Immunodeficiency Virus-infected patients with oropharyngeal candidiasis due to Candida albicans
33. Failure of all antifungal therapy for infection due to Candida albicans: A new AIDS-related problem?
34. Point prevalence of oropharyngeal carriage of fluconazole-resistant Candida in Human Immunodeficiency virus-infected patients
35. Random amplification of polymorphic DNA and microsatellite genotyping of pre and posttreatment isolates of Candida spp. From human immunodeficiency virus-infected patients on different fluconazole regimens
36. A randomized trial of continuous or intermittent therapy with Fluconazole for oropharyngeal candidiasis in HIV-infected patients: Clinical outcomes and development of Fluconazole resistance
37. Resolution of azole-resistant oropharyngeal candidiasis after initiation of potent combination antiretroviral therapy
38. Effect of nystatin in the treatment of denture stomatitis
39. Treatment of candidal leukoplakia with fluconazole
40. Effect of treatment of palatal inflammatory papillary hyperplasia with local and systemic antifungal agents accompained by renewal of complete dentures
41. Variations in fluconazole susceptibility and DNA subtyping of multiple Candida albicans colonies from patients with AIDS and oral candidiasis suffering one or more episodes of infection
42. Mucosal candidal colonization and candidiasis in women with or at risk for human immunodeficiency virus infection
43. Effects of an oral health program on the occurrence of oral candidosis in a long-term care facility
44. An investigation of the efficacy of nystatin for the treatment of chronic atrophic candidosis (denture-sore-mouth)
45. Denture stomatitis. The effect of antifungal and prosthetic treatment
46. Nystatin and amphotericin B in the treatment of denture-related candidiasis
47. Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis
48. Ketoconazole resistant oral candidiasis in HIV-infected patients
49. Infection due to fluconazole-resistant Candida in patients with AIDS: Prevalence and microbiology